Abstract
The systemic immune response toHelicobacter pylori was studied in 247 infected adult patients before antimicrobial therapy and at different intervals following therapy. Endoscopy with simultaneous collection of biopsies was performed in all patients immediately before treatment, 4 to 6 weeks after the end of therapy and 6 to 12 months later. A14C-urea breath test was performed 3 to 6 months after the end of treatment. Biopsy specimens were cultured and examined histologically using Giemsa stain. Sera were tested forHelicobacter pylori IgG antibodies with a commercial enzyme immunoassay using species-specific antigens. Overall,Helicobacter pylori was eradicated in 120 patients while the other 127 remained infected with the organism. The follow-up period ranged from 4 weeks to 33 months (mean 10.2 months). Pretreatment IgG levels did not differ significantly between the two groups of patients. Six weeks after the end of treatment a slight but definite decrease in the IgG antibody levels was seen irrespective of treatment success. In the 127 patients who remainedHelicobacter pylori-positive, the level of IgG antibodies remained stable or increased with time. A continuous fall in antibody levels was observed following bacterial eradication in the other 120 patients, but the difference in antibody levels between treatment responders and nonresponders became significant only more than six months after the end of treatment (p=0.001). Serological testing may be useful for monitoring the outcome of long-term treatment ofHelicobacter pylori infection and obviate the need for endoscopy.
Similar content being viewed by others
References
Dooley CP, Cohen H: The clinical significance ofHelicobacter pylori. Annals of Internal Medicine 1988, 108: 70–78.
Blaser MJ:Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. Journal of Infectious Diseases 1990, 161: 626–633.
Graham DY:Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989, 96: 615–625.
Dixon MF:Campylobacter pylori and chronic gastritis. In: Rathbone BJ, Heatley RV (ed):Campylobacter pylori and gastroduodenal disease. Blackwell Scientific Publications, Oxford, 1989, p. 106–116.
Jones DM, Eldridge J, Fox AJ, Sethi P, Whorwell PJ: Antibody to the gastric Campylobacter-like organism(“Campylobacter pyloridis”)-clinical correlations and distribution in the normal population. Journal of Medical Microbiology 1986, 22: 57–62.
Langenberg W, Rauws EAJ, Houthoff HJ, Oudbier JH, van Bohemen CG, Tygat GNJ, Rietra PJGM: Follow-up study of individuals with untreatedCampylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia. Journal of Infectious Diseases 1988, 157: 1245–1249.
Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ:Campylobacter pylori antibodies in humans. Annals of Internal Medicine 1989, 109: 11–17.
Goodwin CS, Blincow E, Peterson G, Sanderson C, Cheng W, Marshall BJ, Warren JR, McCulloch R: Enzyme-linked immunosorbent assay forCampylobacter pyloridis: correlation with presence ofC. pyloridis in gastric mucosa. Journal of Infectious Diseases 1987, 155: 488–494.
Newell DG, Stacey AR: The serology ofCampylobacter pylori infection. In: Rathbone BJ, Heatley RV (ed):Campylobacter pylori and gastroduodenal disease. Blackwell, Oxford, 1989, p. 74–82.
Evans DJ, Evans DG, Graham DY, Klein PD: A sensitive and specific serologic test for detection ofCampylobacter pylori infection. Gastroenterology 1989, 96: 1004–1008.
Newell DG, Rathbone BJ: The serodiagnosis ofCampylobacter pylori infection. Serodiagnosis and Immunotherapy in Infectious Disease 1989, 3: 1–6.
Sobala GM, Crabtree JE, Pentith JA, Rathbone BJ, Shallcross TM, Wyatt JI, Dixon MF, Heatley RV, Axon ATR: Screening dyspepsia by serology toHelicobacter pylori. Lancet 1991, 338: 94–96.
Mégraud F, Brassens-Rabbé MP, Denis F, Belbouri A, Quynh Hoa D: Seroepidemiology ofCampylobacter pylori infection in various populations. Journal of Clinical Microbiology 1989, 27: 1870–1873.
Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM: Intrafamilial clustering ofHelicobacter pylori infection. New England Journal of Medicine 1990, 332: 359–363.
von Wulffen H, Grote HJ: Enzyme-linked immunosorbent assay for detection of immunoglobulin A and G antibodies toCampylobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 559–565.
Vaira D, Holton J, Cairns SR, Falzon M, Polydorou A, Dowsett JF, Salmon PR: Antibody titres toCampylobacter pylori after treatment for gastritis. British Medical Journal 1988, 297: 397.
van Bohemen CG, Langenberg ML, Rauws EAJ, Oudbier J, Weterings E, Zanen HC: Rapidly decreased serum IgG toCampylobacter pylori following elimination ofCampylobacter in histological chronic biopsyCampylobacter-positive gastritis. Immunology Letters 1989, 20: 59–62.
Gobert B, Bene MC, de Korwin JD, Faure G: Isotype evolution in the follow-up study of patients withCampylobacter pylori associated gastritis. Gastroenterologie Clinique et Biologique 1989, 13: 880–883.
Rolke J, Börsch G, Geis G, Mai U, Opferkuch W: Die Serodiagnostik vonCampylobacter pylori. Immunität und Infektion 1989, 17: 78–82.
Newell DG, Bell GD, Weil J, Jones P, Grant P, Harrison G: The effect of treatment on circulating anti-Helicobacter pylori antibodies — a two year follow-up study. In: Malfertheiner P, Ditschuneit H (ed):Helicobacter pylori, gastritis and peptic ulcer disease. Springer Verlag, Berlin, 1990, p. 172–175.
Hirschl AM, Hentschel E, Berger J, Nemec H, Rotter ML: Treatment ofHelicobacter pylori infections with amoxycillin plus metronidazole: bacteriological, serological and histological results. European Journal of Gastroenterology and Hepatology 1991, 3: 3–7.
Veenendaal RA, Pena AS, Endtz HP, van der Elst MM, van Duijn W, Eulderink F, Kreuning J, Lamers CB: Long term serological surveillance after treatment ofHelicobacter pylori infection. Gut 1991, 31: 1291–1294.
Glupczynski Y, Burette A: EradicatingHelicobacter pylori. Lancet 1992, 339: 54–55.
Goossens H, Glupczynski Y, Burette A, Van den Borre C, Butzler JP: Evaluation of a commercially available second generation IgG enzyme immunoassay to detectHelicobacter pylori infection. Journal of Clinical Microbiology 1992, 30: 176–180.
Price AB: The Sydney system: histological division. Journal of Gastroenterology and Hepatology 1991, 6: 209–222.
Verhas M, Conti S, Cadranel S, Glupczynski Y, Van Tricht L, Deltenre M: Accuracy of urea C-14 breath test in detection ofCampylobacter pylori. In: Schmidt H, Buraggi G (ed): Trends and possibilities in nuclear medicine. Schattauer, Berlin, p. 376–379.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227: 680–685.
Hirschl AM, Pletschette M, Hirschl MH, Berger J, Stanek G, Rotter ML: Comparison of different antigen preparations in an evaluation of the immune response toCampylobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 570–575.
Apel I, Jacobs E, Kist M, Bredt W: Antibody response of patients against a 120 kDa surface protein ofCampylobacter pylori. Zentralblatt Bakteriologie Hygiene 1988, 268: 271–276.
von Wulffen H, Grote HJ, Gaterman S, Lonig T, Berger J, Rotter ML: Immunoblot analysis of immune response toCampylobacter pylori and its clinical associations. Journal of Clinical Pathology 1988, 41: 653–659.
Drouet EB, Denoyel GA, Boude M, Wallano E, Andujar M, De Montclos HP: Characterization of an immunoreactive species-specific 19-kilodalton outer membrane protein fromHelicobacter pylori by using a monoclonal antibody. Journal of Clinical Microbiology 1991, 29: 1620–1624.
Steer HW, Hawtin PR, Newell DG: An ELISA technique for the diagnosis ofCampylobacter pyloridis infection in patients with gastritis and benign duodenal ulceration. Serodiagnosis and Immunotherapy in Infectious Disease 1987, 1: 253–259.
Gnarpe H, Gnarpe J, Blomqvist C, Unge P: Evaluation of three commercial antibody kits for diagnosis ofHelicobacter pylori infection. Microbial Ecology in Health and Disease 1991, 4, Supplement: 165.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glupczynski, Y., Burette, A., Goossens, H. et al. Effect of antimicrobial therapy on the specific serological response toHelicobacter pylori infection. Eur. J. Clin. Microbiol. Infect. Dis. 11, 583–588 (1992). https://doi.org/10.1007/BF01961663
Issue Date:
DOI: https://doi.org/10.1007/BF01961663